Ikena Oncology (IKNA) announced the appointment of Kristin Yarema, Ph.D. as Chief Executive Officer of ImageneBio, of the combined company after the anticipated closing. Dr. Yarema joins the team after most recently serving as President and Chief Executive Officer and as a member of the Board of Directors of Poseida Therapeutics (PSTX)
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IKNA: